Home

Unfall G Memo myocarditis cases 2022 Für einen Tagesausflug Asser Angebot

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to  myocarditis-associated antigens - eBioMedicine
Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens - eBioMedicine

Cureus | COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40  Case Reports | Article
Cureus | COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40 Case Reports | Article

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines |  tctmd.com
Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines | tctmd.com

Trends in myocarditis incidence, complications and mortality in Sweden from  2000 to 2014 | Scientific Reports
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization  | NEJM
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM

Reports of myocarditis and pericarditis following mRNA COVID-19  vaccination: a systematic review of spontaneously reported data from the  UK, Europe and the USA and of the scientific literature | BMJ Open
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature | BMJ Open

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination | NEJM
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination | NEJM

Reports of myocarditis and pericarditis following mRNA COVID-19  vaccination: a systematic review of spontaneously reported data from the  UK, Europe and the USA and of the scientific literature | BMJ Open
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature | BMJ Open

Frontiers | Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A  Case Report and Literature Review
Frontiers | Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review

Update on myocarditis following mRNA COVID-19 vaccination
Update on myocarditis following mRNA COVID-19 vaccination

Association Between COVID-19 and Myocarditis Using Hospital-Based  Administrative Data — United States, March 2020–January 2021 | MMWR
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR

Myocarditis low after COVID-19 vaccination, but odds elevated in male  teens, young adults
Myocarditis low after COVID-19 vaccination, but odds elevated in male teens, young adults

Increased emergency cardiovascular events among under-40 population in  Israel during vaccine rollout and third COVID-19 wave | Scientific Reports
Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave | Scientific Reports

Frontiers | Global, Regional, and National Burden of Myocarditis and  Cardiomyopathy, 1990–2017
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a  nationwide setting - Annals Singapore
Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting - Annals Singapore

Myocarditis Risk 17 Times Higher for Unvaccinated Patients Ages 12-30 Who  Get COVID-19 Than COVID-Vaccinated Patients
Myocarditis Risk 17 Times Higher for Unvaccinated Patients Ages 12-30 Who Get COVID-19 Than COVID-Vaccinated Patients

Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis,  pathophysiology, therapy, and outcomes put into perspective. A clinical  consensus document supported by the Heart Failure Association of the  European Society of Cardiology (ESC ...
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...

Case Report: Myocarditis After COVID-19 Vaccination - Case Series and  Literature Review
Case Report: Myocarditis After COVID-19 Vaccination - Case Series and Literature Review

Endomyocardial biopsy-confirmed myocarditis and inflammatory  cardiomyopathy: clinical profile and prognosis | Revista Española de  Cardiología
Endomyocardial biopsy-confirmed myocarditis and inflammatory cardiomyopathy: clinical profile and prognosis | Revista Española de Cardiología

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination  Compared With Viral Myocarditis | Journal of the American College of  Cardiology
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis | Journal of the American College of Cardiology

JCM | Free Full-Text | COVID-19 Related Myocarditis in Adults: A Systematic  Review of Case Reports
JCM | Free Full-Text | COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports

Systematic analysis of drug-associated myocarditis reported in the World  Health Organization pharmacovigilance database | Nature Communications
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications

Need to Know: Heart Problems After COVID-19 | KNOWTIFY
Need to Know: Heart Problems After COVID-19 | KNOWTIFY

Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory  Medicine
Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory Medicine